Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandro Cosconati

Showing results (121-130 of 150) with videos related to

Pageof 15
Sort By:
Bioorganic & Medicinal Chemistry|April 17, 2018
Cationic nucleopeptides as novel non-covalent carriers for the delivery of peptide nucleic acid (PNA) and RNA oligomersStefano Tomassi, Caterina Ieranò, Maria Emilia Mercurio, et al.
Journal of Medicinal Chemistry|August 2, 2017
Development of Novel Peptide-Based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Diseases (NTDs)Santo Previti, Roberta Ettari, Sandro Cosconati, et al.
Oncotarget|September 2, 2015
Src inhibitors act through different mechanisms in Non-Small Cell Lung Cancer models depending on EGFR and RAS mutational statusLuigi Formisano, Valentina D'Amato, Alberto Servetto, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|July 1, 2020
Disulfide Bond Replacement with 1,4- and 1,5-Disubstituted [1,2,3]-Triazole on C-X-C Chemokine Receptor Type 4 (CXCR4) Peptide Ligands: Small Changes that Make Big DifferencesStefano Tomassi, Anna Maria Trotta, Caterina Ieranò, et al.
European Journal of Medicinal Chemistry|November 18, 2011
Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimizationValeria La Pietra, Luciana Marinelli, Sandro Cosconati, et al.
European Journal of Medicinal Chemistry|May 16, 2025
Identification of isoxazole-based TRPA1 inhibitors with analgesic effects in vivoValentina Albanese, Matilde Marini, Martina Tesi, et al.
Journal of Medicinal Chemistry|May 28, 2009
Identification of anxiolytic/nonsedative agents among indol-3-ylglyoxylamides acting as functionally selective agonists at the gamma-aminobutyric acid-A (GABAA) alpha2 benzodiazepine receptorSabrina Taliani, Barbara Cosimelli, Federico Da Settimo, et al.
Cell Chemical Biology|December 8, 2023
Irreversible inhibition of TRF2<sub>TRFH</sub> recruiting functions by a covalent cyclic peptide induces telomeric replication stress in cancer cellsAlexander P Sobinoff, Salvatore Di Maro, Ronnie R J Low, et al.
Journal of Medicinal Chemistry|January 28, 2009
Specific targeting of highly conserved residues in the HIV-1 reverse transcriptase primer grip region. 2. Stereoselective interaction to overcome the effects of drug resistant mutationsStefania Butini, Margherita Brindisi, Sandro Cosconati, et al.
Journal of Medicinal Chemistry|August 31, 2013
Phenylpyrazolo[1,5-a]quinazolin-5(4H)-one: a suitable scaffold for the development of noncamptothecin topoisomerase I (Top1) inhibitorsSabrina Taliani, Isabella Pugliesi, Elisabetta Barresi, et al.
Pageof 15

Showing results (121-130 of 150) with videos related to

Sort By:
Pageof 15
Bioorganic & Medicinal Chemistry|April 17, 2018
Cationic nucleopeptides as novel non-covalent carriers for the delivery of peptide nucleic acid (PNA) and RNA oligomersStefano Tomassi, Caterina Ieranò, Maria Emilia Mercurio, et al.
Journal of Medicinal Chemistry|August 2, 2017
Development of Novel Peptide-Based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Diseases (NTDs)Santo Previti, Roberta Ettari, Sandro Cosconati, et al.
Oncotarget|September 2, 2015
Src inhibitors act through different mechanisms in Non-Small Cell Lung Cancer models depending on EGFR and RAS mutational statusLuigi Formisano, Valentina D'Amato, Alberto Servetto, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|July 1, 2020
Disulfide Bond Replacement with 1,4- and 1,5-Disubstituted [1,2,3]-Triazole on C-X-C Chemokine Receptor Type 4 (CXCR4) Peptide Ligands: Small Changes that Make Big DifferencesStefano Tomassi, Anna Maria Trotta, Caterina Ieranò, et al.
European Journal of Medicinal Chemistry|November 18, 2011
Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimizationValeria La Pietra, Luciana Marinelli, Sandro Cosconati, et al.
European Journal of Medicinal Chemistry|May 16, 2025
Identification of isoxazole-based TRPA1 inhibitors with analgesic effects in vivoValentina Albanese, Matilde Marini, Martina Tesi, et al.
Journal of Medicinal Chemistry|May 28, 2009
Identification of anxiolytic/nonsedative agents among indol-3-ylglyoxylamides acting as functionally selective agonists at the gamma-aminobutyric acid-A (GABAA) alpha2 benzodiazepine receptorSabrina Taliani, Barbara Cosimelli, Federico Da Settimo, et al.
Cell Chemical Biology|December 8, 2023
Irreversible inhibition of TRF2<sub>TRFH</sub> recruiting functions by a covalent cyclic peptide induces telomeric replication stress in cancer cellsAlexander P Sobinoff, Salvatore Di Maro, Ronnie R J Low, et al.
Journal of Medicinal Chemistry|January 28, 2009
Specific targeting of highly conserved residues in the HIV-1 reverse transcriptase primer grip region. 2. Stereoselective interaction to overcome the effects of drug resistant mutationsStefania Butini, Margherita Brindisi, Sandro Cosconati, et al.
Journal of Medicinal Chemistry|August 31, 2013
Phenylpyrazolo[1,5-a]quinazolin-5(4H)-one: a suitable scaffold for the development of noncamptothecin topoisomerase I (Top1) inhibitorsSabrina Taliani, Isabella Pugliesi, Elisabetta Barresi, et al.
Pageof 15